ECSP20042134A - Combinaciones de lípidos - Google Patents
Combinaciones de lípidosInfo
- Publication number
- ECSP20042134A ECSP20042134A ECSENADI202042134A ECDI202042134A ECSP20042134A EC SP20042134 A ECSP20042134 A EC SP20042134A EC SENADI202042134 A ECSENADI202042134 A EC SENADI202042134A EC DI202042134 A ECDI202042134 A EC DI202042134A EC SP20042134 A ECSP20042134 A EC SP20042134A
- Authority
- EC
- Ecuador
- Prior art keywords
- combinations
- compositions
- lipid combinations
- relates
- krill
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Insects & Arthropods (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente invención se relaciona en general con combinaciones de lípidos marinos. En particular se relaciona con una combinación de lípidos marinos obtenidos de Perna canaliculus y kril, composiciones y preparaciones que comprenden dichas combinaciones y el uso terapéutico de dichas combinaciones y composiciones. También se describen procesos para la elaboración de aceites de kril y su uso en las combinaciones y composiciones.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017905181A AU2017905181A0 (en) | 2017-12-22 | Lipid combinations | |
| PCT/IB2018/060482 WO2019123400A1 (en) | 2017-12-22 | 2018-12-21 | Lipid combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP20042134A true ECSP20042134A (es) | 2020-12-31 |
Family
ID=66993218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202042134A ECSP20042134A (es) | 2017-12-22 | 2020-07-22 | Combinaciones de lípidos |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US11654163B2 (es) |
| EP (1) | EP3727404B1 (es) |
| JP (2) | JP7685313B2 (es) |
| KR (2) | KR20250153312A (es) |
| CN (2) | CN121313680A (es) |
| AR (1) | AR117943A1 (es) |
| AU (2) | AU2018392997A1 (es) |
| BR (1) | BR112020012770A2 (es) |
| CL (1) | CL2020001649A1 (es) |
| DK (1) | DK3727404T3 (es) |
| DO (1) | DOP2020000131A (es) |
| EA (1) | EA202091551A1 (es) |
| EC (1) | ECSP20042134A (es) |
| ES (1) | ES2959633T3 (es) |
| FI (1) | FI3727404T3 (es) |
| HR (1) | HRP20231254T1 (es) |
| HU (1) | HUE064489T2 (es) |
| IL (1) | IL275583B2 (es) |
| JO (1) | JOP20200108B1 (es) |
| LT (1) | LT3727404T (es) |
| MX (1) | MX2019014252A (es) |
| MY (1) | MY205499A (es) |
| NI (1) | NI202000047A (es) |
| NZ (1) | NZ755776A (es) |
| PE (1) | PE20211308A1 (es) |
| PH (1) | PH12020550965A1 (es) |
| PL (1) | PL3727404T3 (es) |
| PT (1) | PT3727404T (es) |
| RS (1) | RS64705B1 (es) |
| SA (1) | SA520412019B1 (es) |
| SG (1) | SG11202003935QA (es) |
| SI (1) | SI3727404T1 (es) |
| SM (1) | SMT202300351T1 (es) |
| TW (1) | TWI815840B (es) |
| UA (1) | UA126417C2 (es) |
| UY (1) | UY38033A (es) |
| WO (1) | WO2019123400A1 (es) |
| ZA (1) | ZA202003454B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116875368A (zh) * | 2023-07-07 | 2023-10-13 | 中国海洋大学 | 贻贝油及其制备方法以及在制备提高认知功能制品中的应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN531195A0 (en) * | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
| CA2251265A1 (en) | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Process for lipid extraction of aquatic animal tissues producing a dehydrated residue |
| US6596303B1 (en) | 1999-03-22 | 2003-07-22 | Mars Incorporated | Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
| ATE554779T1 (de) | 2001-06-18 | 2012-05-15 | Neptune Technologies & Bioressources Inc | Krill zur prävention und/oder behandlung von herz-kreislauf-erkrankungen |
| US8030348B2 (en) * | 2001-07-27 | 2011-10-04 | Neptune Technologies & Bioressources, Inc. | Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| CA2554932A1 (en) | 2004-01-30 | 2005-08-11 | Bionovate Limited | Solvent extraction of lipids such as essential fatty acids |
| GB0411166D0 (en) * | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Treatment for asthma and arthritis |
| WO2006052150A1 (en) | 2004-11-15 | 2006-05-18 | University Of Otago | Mussel extract composition with enhanced anti-inflammatory activity |
| WO2006128244A1 (en) | 2005-06-03 | 2006-12-07 | Mc Farlane Marketing (Aust.) Pty. Ltd. | Lipid extract of mussels and method for preparation thereof |
| WO2007123424A1 (en) | 2006-04-20 | 2007-11-01 | Owen John Catchpole | Process for separating lipid materials |
| NZ547429A (en) | 2006-05-24 | 2009-09-25 | Ind Res Ltd | Extraction of highly unsaturated lipids with liquid dimethyl ether |
| JP5215858B2 (ja) | 2006-09-22 | 2013-06-19 | 株式会社ハイマート | 抗血管新生作用を有する抽出物とレシチンを含有する抗血管新生組成物 |
| AU2011213836B2 (en) | 2007-03-28 | 2013-11-14 | Aker Biomarine Antarctic As | Bioeffective krill oil compositions |
| AU2008231570C1 (en) | 2007-03-28 | 2014-11-27 | Aker Biomarine Human Ingredients As | Bioeffective krill oil compositions |
| US8557297B2 (en) * | 2008-09-12 | 2013-10-15 | Olympic Seafood, As | Method for processing crustaceans and products thereof |
| US8481072B2 (en) | 2009-07-23 | 2013-07-09 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain |
| US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
| EP2493478B8 (en) * | 2009-10-29 | 2018-03-28 | Acasti Pharma, Inc. | Concentrated therapeutic phospholipid compositions |
| AP3082A (en) | 2009-10-30 | 2015-01-31 | Tharos Ltd | Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
| US9415035B2 (en) | 2010-09-17 | 2016-08-16 | Maine Natural Health Company, Inc. | Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof |
| US20120231087A1 (en) * | 2011-03-07 | 2012-09-13 | Olympic Seafood | Compositions And Methods for Nutritional Supplementation |
| SI2697345T1 (sl) | 2011-04-14 | 2016-08-31 | Polar Omega A/S | Proces za izolacijo fosfolipida |
| WO2013052587A2 (en) | 2011-10-04 | 2013-04-11 | Wake Forest University Health Sciences | Methods for identifying and treating an individual with an inflammatory disease using fatty acid-based therapies |
| RU2526826C2 (ru) | 2012-10-24 | 2014-08-27 | Николай Владимирович Соловьёв | Композиция для парентерального введения, способ получения и применение композиции |
| GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
| GB201402450D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Liquid phospholipid-containing compositions for preperation of pharmaceuticals |
| WO2015142705A1 (en) | 2014-03-18 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to alleviate joint pain using algae based oils |
| US10463699B2 (en) | 2016-04-04 | 2019-11-05 | Omeza LLC | Fish oil topical composition |
| CN105685482A (zh) | 2016-04-21 | 2016-06-22 | 中国海洋大学 | 一种提高石斑鱼稚鱼抗应激能力的微颗粒饲料 |
| CN106306554B (zh) | 2016-08-16 | 2019-10-11 | 中国水产科学研究院黄海水产研究所 | 一种可替代鲜活饵料的凡纳滨对虾亲虾饲料 |
| CN111432654A (zh) | 2017-12-04 | 2020-07-17 | 雾凇科技有限公司 | 从甲壳类捕获物中生产蛋白质磷脂复合物的方法 |
-
2018
- 2018-12-21 UY UY0001038033A patent/UY38033A/es unknown
- 2018-12-21 ES ES18892617T patent/ES2959633T3/es active Active
- 2018-12-21 PL PL18892617.4T patent/PL3727404T3/pl unknown
- 2018-12-21 AU AU2018392997A patent/AU2018392997A1/en not_active Abandoned
- 2018-12-21 LT LTEPPCT/IB2018/060482T patent/LT3727404T/lt unknown
- 2018-12-21 SI SI201830996T patent/SI3727404T1/sl unknown
- 2018-12-21 IL IL275583A patent/IL275583B2/en unknown
- 2018-12-21 BR BR112020012770-1A patent/BR112020012770A2/pt unknown
- 2018-12-21 AR ARP180103836A patent/AR117943A1/es unknown
- 2018-12-21 MX MX2019014252A patent/MX2019014252A/es unknown
- 2018-12-21 CN CN202511452174.6A patent/CN121313680A/zh active Pending
- 2018-12-21 WO PCT/IB2018/060482 patent/WO2019123400A1/en not_active Ceased
- 2018-12-21 US US16/481,444 patent/US11654163B2/en active Active
- 2018-12-21 TW TW107146439A patent/TWI815840B/zh active
- 2018-12-21 HR HRP20231254TT patent/HRP20231254T1/hr unknown
- 2018-12-21 KR KR1020257033465A patent/KR20250153312A/ko active Pending
- 2018-12-21 JO JOP/2020/0108A patent/JOP20200108B1/ar active
- 2018-12-21 UA UAA202004611A patent/UA126417C2/uk unknown
- 2018-12-21 FI FIEP18892617.4T patent/FI3727404T3/fi active
- 2018-12-21 PE PE2020000821A patent/PE20211308A1/es unknown
- 2018-12-21 KR KR1020197034981A patent/KR20200102914A/ko not_active Ceased
- 2018-12-21 SM SM20230351T patent/SMT202300351T1/it unknown
- 2018-12-21 NZ NZ755776A patent/NZ755776A/en unknown
- 2018-12-21 CN CN201880014073.2A patent/CN110337300B/zh active Active
- 2018-12-21 EP EP18892617.4A patent/EP3727404B1/en active Active
- 2018-12-21 HU HUE18892617A patent/HUE064489T2/hu unknown
- 2018-12-21 DK DK18892617.4T patent/DK3727404T3/da active
- 2018-12-21 SG SG11202003935QA patent/SG11202003935QA/en unknown
- 2018-12-21 MY MYPI2020003153A patent/MY205499A/en unknown
- 2018-12-21 PT PT188926174T patent/PT3727404T/pt unknown
- 2018-12-21 EA EA202091551A patent/EA202091551A1/ru unknown
- 2018-12-21 JP JP2019560209A patent/JP7685313B2/ja active Active
- 2018-12-21 RS RS20230933A patent/RS64705B1/sr unknown
-
2020
- 2020-05-21 SA SA520412019A patent/SA520412019B1/ar unknown
- 2020-06-09 ZA ZA2020/03454A patent/ZA202003454B/en unknown
- 2020-06-18 CL CL2020001649A patent/CL2020001649A1/es unknown
- 2020-06-18 NI NI202000047A patent/NI202000047A/es unknown
- 2020-06-22 PH PH12020550965A patent/PH12020550965A1/en unknown
- 2020-06-22 DO DO2020000131A patent/DOP2020000131A/es unknown
- 2020-07-22 EC ECSENADI202042134A patent/ECSP20042134A/es unknown
-
2021
- 2021-07-08 AU AU2021204787A patent/AU2021204787C1/en active Active
-
2023
- 2023-06-06 JP JP2023093106A patent/JP2023113819A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
| ECSP19015192A (es) | Composiciones y métodos de inhibir masp-3 para el tratamiento de diversas enfermedades y trastornos | |
| MX2019011764A (es) | Composiciones limpiadoras y usos de las mismas. | |
| CL2018003582A1 (es) | Composiciones para modular la expresión de c9orf72 (divisional solicitud 201702567) | |
| MX2018015252A (es) | Inhibidores de la interaccion de menina-leucemia de linaje mixto. | |
| SV2018005643A (es) | Composiciones de insulina de rapida accion | |
| CL2021001395A1 (es) | Compuestos derivados de panteteínas cíclicas; composición farmacéutica que los comprende; y su uso para aumentar las concentraciones de acetil-coa, para el tratamiento de cáncer, enfermedad inflamatoria, enfermedad neurodegenerativa, esclerosis múltiple, entre otras enfermedades. | |
| MX2018003700A (es) | Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de higado graso, y uso de los mismos. | |
| CO2017001212A2 (es) | Moléculas que tienen ciertas utilidades pesticidas y productos intermediarios, composiciones y procesos relacionados con las mismas | |
| MX372988B (es) | Composiciones oftalmicas estabilizadas de omega 3. | |
| MX2018015930A (es) | Metodos para hacer agentes de contraste por ultrasonido. | |
| CL2019001053A1 (es) | Formulaciones farmacéuticas y métodos para prepararlas. | |
| MX2018012285A (es) | Metodos de tratamiento para enfermedades colestasicas y fibroticas. | |
| MX391152B (es) | Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas. | |
| CL2017003144A1 (es) | Péptidos lipidados resistentes a proteasas | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| PY1943738A (es) | Composiciones herbicidas | |
| BR112016026660A2 (pt) | ?produto extemporâneo para cuidados cosméticos e/ou dermatológicos, e, kit de preparação extemporânea de uma composição cosmética e/ou dermatológica? | |
| MX2017004531A (es) | Composiciones para usarse en extraccion de micotoxina. | |
| AR112466A1 (es) | Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método | |
| CL2018001779A1 (es) | Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales. | |
| ECSP20042134A (es) | Combinaciones de lípidos | |
| MX384254B (es) | Formulaciones para mejorar la eficacia de farmacos hidrofobicos. | |
| MX2020012784A (es) | Composicion de relleno a base de grasa. | |
| BR112018071142A2 (pt) | métodos de fabricação de formulações nutricionais |